Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vicks in Japan

This article was originally published in The Tan Sheet

Executive Summary

P&G transfers Vicks medicated cough drop business in Japan to Taisho Pharmaceutical in deal announced May 14. Under agreement, Taisho obtains perpetual license rights to trademark, formula of Vicks Medicated Drops, as well as rights to all product sales; P&G will continue as contract manufacturer "for the foreseeable future," Taisho says. Firm also becomes exclusive sales agent of VicksVapoRub in Japan, although P&G will continue to manufacture the product. P&G says deal is part of its strategic decision to invest in larger markets; aside from Japan, Vicks Medicated Drops are only sold in India, Indonesia, Singapore and are not among top-selling Vicks offerings...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094071

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel